-
2
-
-
0022501517
-
Clinical characteristics and family history in DSM-III obsessive-compulsive disorder
-
Rasmussen SA, Tsuang MT (1986) Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 143: 317-322
-
(1986)
Am J Psychiatry
, vol.143
, pp. 317-322
-
-
Rasmussen, S.A.1
Tsuang, M.T.2
-
3
-
-
0026410690
-
Clomipramine in the treatment of patients with obsessive-compulsive disorder
-
Clomipramine Collaborative Study Group
-
Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 48: 730-738
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 730-738
-
-
-
4
-
-
0344532729
-
Chlorpromazine in obsessive compulsive and allied disorders
-
Trethowan JWH, Scott PAL (1955) Chlorpromazine in obsessive compulsive and allied disorders. Lancet: 781-785
-
(1955)
Lancet
, pp. 781-785
-
-
Trethowan, J.W.H.1
Scott, P.A.L.2
-
5
-
-
0014131311
-
Treatment of the phobic obsessive compulsive patient with oxazepam, an improved benzodi-azepine compound
-
Orvin GH (1967) Treatment of the phobic obsessive compulsive patient with oxazepam, an improved benzodi-azepine compound. Psychosomatics 8: 278-280
-
(1967)
Psychosomatics
, vol.8
, pp. 278-280
-
-
Orvin, G.H.1
-
6
-
-
0344101309
-
A controlled trial with valium in obsessive compulsive states
-
Rao AV (1964) A controlled trial with valium in obsessive compulsive states. J Indian Med Assoc 42: 564-567
-
(1964)
J Indian Med Assoc
, vol.42
, pp. 564-567
-
-
Rao, A.V.1
-
7
-
-
0020582680
-
Obsessive compulsive disorder: A double blind trial of clomipramine and clorgyline
-
Insel TR, Murphy DL, Cohen RM, Atterman I, Kitts C, Linnoila M (1983) Obsessive compulsive disorder: a double blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 40: 605-612
-
(1983)
Arch Gen Psychiatry
, vol.40
, pp. 605-612
-
-
Insel, T.R.1
Murphy, D.L.2
Cohen, R.M.3
Atterman, I.4
Kitts, C.5
Linnoila, M.6
-
9
-
-
0023472494
-
Fluvoxamine treatment of obsessive compulsive disorder
-
Perse TC, Greist JH, Jefferson JW, Rosenfeld R, Dar R (1987) Fluvoxamine treatment of obsessive compulsive disorder. Am J Psychiatry 144: 1543-1548
-
(1987)
Am J Psychiatry
, vol.144
, pp. 1543-1548
-
-
Perse, T.C.1
Greist, J.H.2
Jefferson, J.W.3
Rosenfeld, R.4
Dar, R.5
-
10
-
-
0025038717
-
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive compulsive disorder
-
Chouinard G, Goodman W, Greist JH (1990) Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive compulsive disorder. Psychopharmacol Bull 26: 279-284
-
(1990)
Psychopharmacol Bull
, vol.26
, pp. 279-284
-
-
Chouinard, G.1
Goodman, W.2
Greist, J.H.3
-
11
-
-
0025179467
-
A controlled study of fluvoxamine and exposure in obsessive compulsive disorder
-
Cottraux J, Mollard E, Bouvard M, Marks I, Sluys M, Nury AM, et al (1990) A controlled study of fluvoxamine and exposure in obsessive compulsive disorder. Int Clin Psychopharmacol 5: 17-30
-
(1990)
Int Clin Psychopharmacol
, vol.5
, pp. 17-30
-
-
Cottraux, J.1
Mollard, E.2
Bouvard, M.3
Marks, I.4
Sluys, M.5
Nury, A.M.6
-
12
-
-
0025294010
-
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine
-
Goodman WK, Price LH, Delgado PL, Krystal JH, Nagy LM, Rasmussen SA, et al (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry 47: 577-585
-
(1990)
Arch Gen Psychiatry
, vol.47
, pp. 577-585
-
-
Goodman, W.K.1
Price, L.H.2
Delgado, P.L.3
Krystal, J.H.4
Nagy, L.M.5
Rasmussen, S.A.6
-
13
-
-
0344532728
-
Fluvoxamine treatment of obsessive-compulsive disorder
-
Florence, Italy
-
Greist JH (1991) Fluvoxamine treatment of obsessive-compulsive disorder. Presented at the 5th World Congress of Biological Psychiatry, Florence, Italy
-
(1991)
5th World Congress of Biological Psychiatry
-
-
Greist, J.H.1
-
15
-
-
0022612567
-
An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder
-
Fontaine R, Chouinard G (1986) An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 6: 98-101
-
(1986)
J Clin Psychopharmacol
, vol.6
, pp. 98-101
-
-
Fontaine, R.1
Chouinard, G.2
-
16
-
-
0024338042
-
Open trial of fluoxetine in obsessive-compulsive disorder
-
Jenike MA, Buttolph L, Baer L, Ricciardi J, Holland A (1989) Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 146: 909-911
-
(1989)
Am J Psychiatry
, vol.146
, pp. 909-911
-
-
Jenike, M.A.1
Buttolph, L.2
Baer, L.3
Ricciardi, J.4
Holland, A.5
-
17
-
-
0024847610
-
Fluoxetine treatment of obsessive-compulsive disorder: An open clinical trial
-
Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J, Papp L, et al (1989) Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial. J Clin Psychopharmacol 9: 423-427
-
(1989)
J Clin Psychopharmacol
, vol.9
, pp. 423-427
-
-
Liebowitz, M.R.1
Hollander, E.2
Schneier, F.3
Campeas, R.4
Hatterer, J.5
Papp, L.6
-
18
-
-
0027818752
-
A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder
-
Montgomery SA, McIntrye A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, et al (1993) A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. Eur Neuropsychopharmacol 3: 143-154
-
(1993)
Eur Neuropsychopharmacol
, vol.3
, pp. 143-154
-
-
Montgomery, S.A.1
McIntrye, A.2
Osterheider, M.3
Sarteschi, P.4
Zitterl, W.5
Zohar, J.6
-
19
-
-
0028359427
-
A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder
-
Tollefson G, Rampey Jr. AH, Potvin JH, Jenike MA, Rush AJ, Dominguez RA, et al. (1994) A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 51: 559-657
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 559-657
-
-
Tollefson, G.1
Rampey A.H., Jr.2
Potvin, J.H.3
Jenike, M.A.4
Rush, A.J.5
Dominguez, R.A.6
-
20
-
-
0003361529
-
CGI: Clinical global impressions
-
Guy E (ed) NIMH, Rockville, MD
-
National Institute of Mental Health (1976) CGI: Clinical global impressions. In: Guy E (ed) ECDEU Assessment for Psychopharmacology, Rev. edn. NIMH, Rockville, MD, pp 217-222
-
(1976)
ECDEU Assessment for Psychopharmacology, Rev. Edn.
, pp. 217-222
-
-
-
21
-
-
0024435153
-
The Yale-Brown obsessive compulsive scale. I. Development, use and reliability
-
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. (1989) The Yale-Brown obsessive compulsive scale. I. development, use and reliability. Arch Gen Psychiatry 46: 1006-1011
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 1006-1011
-
-
Goodman, W.K.1
Price, L.H.2
Rasmussen, S.A.3
Mazure, C.4
Fleischmann, R.L.5
Hill, C.L.6
-
22
-
-
0024465894
-
The Yale-Brown obsessive compulsive scale. II. Validity
-
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al (1989) The Yale-Brown obsessive compulsive scale. II. Validity. Arch Gen Psychiatry 46: 1012-1016
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 1012-1016
-
-
Goodman, W.K.1
Price, L.H.2
Rasmussen, S.A.3
Mazure, C.4
Delgado, P.5
Heninger, G.R.6
-
25
-
-
0023742740
-
The evidence for 20 mg a day of fluoxetine as the optimal daily dose in the treatment of depression
-
Altamura AC, Montgomery SA, Wernicke JF (1988) The evidence for 20 mg a day of fluoxetine as the optimal daily dose in the treatment of depression. Br J Psychiatry 153: 109-112
-
(1988)
Br J Psychiatry
, vol.153
, pp. 109-112
-
-
Altamura, A.C.1
Montgomery, S.A.2
Wernicke, J.F.3
-
27
-
-
0028903368
-
Fluoxetine: An overview of its pharmacodynamic and pharmacokinetic properties and review of its therapeutic efficacy in obsessive-compulsive disorder
-
Fulton B, McTavish D (1995) Fluoxetine: An overview of its pharmacodynamic and pharmacokinetic properties and review of its therapeutic efficacy in obsessive-compulsive disorder. CNS Drugs 3: 305-322
-
(1995)
CNS Drugs
, vol.3
, pp. 305-322
-
-
Fulton, B.1
McTavish, D.2
-
28
-
-
0026650332
-
The safety of antidepressants
-
de Jonghe F, Swinkels JA (1992) The safety of antidepressants. Drugs 43: 40-47
-
(1992)
Drugs
, vol.43
, pp. 40-47
-
-
De Jonghe, F.1
Swinkels, J.A.2
-
29
-
-
0029925952
-
Treatment of obsessive-compulsive disorder with fluvoxamine: A multi-center, double-blind placebo-controlled trial
-
Goodman WK, Kozak MJ, Liebowitz M, White KL (1996) Treatment of obsessive-compulsive disorder with fluvoxamine: A multi-center, double-blind placebo-controlled trial. Int Clin Psychopharmacol 11: 21-29
-
(1996)
Int Clin Psychopharmacol
, vol.11
, pp. 21-29
-
-
Goodman, W.K.1
Kozak, M.J.2
Liebowitz, M.3
White, K.L.4
|